Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
45,497
archived clinical trials in
Breast Cancer

Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Mercy and Unity Cancer Center at Mercy Hospital
mi
from
Coon Rapids, MN
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Mercy and Unity Cancer Center at Mercy Hospital
mi
from
Coon Rapids, MN
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Duluth Clinic Cancer Center - Duluth
mi
from
Duluth, MN
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Duluth Clinic Cancer Center - Duluth
mi
from
Duluth, MN
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
CCOP - Duluth
mi
from
Duluth, MN
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
CCOP - Duluth
mi
from
Duluth, MN
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Miller - Dwan Medical Center
mi
from
Duluth, MN
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Miller - Dwan Medical Center
mi
from
Duluth, MN
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Fairview Southdale Hospital
mi
from
Edina, MN
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Fairview Southdale Hospital
mi
from
Edina, MN
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Mercy and Unity Cancer Center at Unity Hospital
mi
from
Fridley, MN
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Mercy and Unity Cancer Center at Unity Hospital
mi
from
Fridley, MN
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Hutchinson Area Health Care
mi
from
Hutchinson, MN
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Hutchinson Area Health Care
mi
from
Hutchinson, MN
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Meeker County Memorial Hospital
mi
from
Lichfield, MN
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Meeker County Memorial Hospital
mi
from
Lichfield, MN
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Immanuel St. Joseph's
mi
from
Mankato, MN
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Immanuel St. Joseph's
mi
from
Mankato, MN
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
HealthEast Cancer Care at St. John's Hospital
mi
from
Maplewood, MN
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
HealthEast Cancer Care at St. John's Hospital
mi
from
Maplewood, MN
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Minnesota Oncology Hematology PA-Maplewood
mi
from
Maplewood, MN
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Minnesota Oncology Hematology PA-Maplewood
mi
from
Maplewood, MN
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Virginia Piper Cancer Institute at Abbott - Northwestern Hospital
mi
from
Minneapolis, MN
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Virginia Piper Cancer Institute at Abbott - Northwestern Hospital
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Hennepin County Medical Center - Minneapolis
mi
from
Minneapolis, MN
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Hennepin County Medical Center - Minneapolis
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Hubert H. Humphrey Cancer Center at North Memorial Outpatient Center
mi
from
Robbinsdale, MN
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Hubert H. Humphrey Cancer Center at North Memorial Outpatient Center
mi
from
Robbinsdale, MN
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
CCOP - Metro-Minnesota
mi
from
Saint Louis Park, MN
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
CCOP - Metro-Minnesota
mi
from
Saint Louis Park, MN
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Park Nicollet Cancer Center
mi
from
Saint Louis Park, MN
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Park Nicollet Cancer Center
mi
from
Saint Louis Park, MN
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
HealthEast Cancer Care at St. Joseph's Hospital
mi
from
Saint Paul, MN
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
HealthEast Cancer Care at St. Joseph's Hospital
mi
from
Saint Paul, MN
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
United Hospital
mi
from
Saint Paul, MN
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
United Hospital
mi
from
Saint Paul, MN
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
St. Francis Cancer Center at St. Francis Medical Center
mi
from
Shakopee, MN
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
St. Francis Cancer Center at St. Francis Medical Center
mi
from
Shakopee, MN
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Regions Hospital Cancer Care Center
mi
from
St. Paul, MN
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Regions Hospital Cancer Care Center
mi
from
St. Paul, MN
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Ridgeview Medical Center
mi
from
Waconia, MN
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Ridgeview Medical Center
mi
from
Waconia, MN
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
HealthEast Cancer Care at Woodwinds Health Campus
mi
from
Woodbury, MN
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
HealthEast Cancer Care at Woodwinds Health Campus
mi
from
Woodbury, MN
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Minnesota Oncology and Hematology PA-Woodbury
mi
from
Woodbury, MN
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Minnesota Oncology and Hematology PA-Woodbury
mi
from
Woodbury, MN
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Missouri Baptist Cancer Center
mi
from
Saint Louis, MO
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Missouri Baptist Cancer Center
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Arch Medical Services, Incorporated at Center for Cancer Care and Research
mi
from
Saint Louis, MO
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Arch Medical Services, Incorporated at Center for Cancer Care and Research
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
CCOP - Montana Cancer Consortium
mi
from
Billings, MT
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
CCOP - Montana Cancer Consortium
mi
from
Billings, MT
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Hematology-Oncology Centers of the Northern Rockies - Billings
mi
from
Billings, MT
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Hematology-Oncology Centers of the Northern Rockies - Billings
mi
from
Billings, MT
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Northern Rockies Radiation Oncology Center
mi
from
Billings, MT
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Northern Rockies Radiation Oncology Center
mi
from
Billings, MT
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
St. Vincent Healthcare Cancer Care Services
mi
from
Billings, MT
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
St. Vincent Healthcare Cancer Care Services
mi
from
Billings, MT
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Billings Clinic - Downtown
mi
from
Billings, MT
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Billings Clinic - Downtown
mi
from
Billings, MT
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Bozeman Deaconess Cancer Center
mi
from
Bozeman, MT
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Bozeman Deaconess Cancer Center
mi
from
Bozeman, MT
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
St. James Healthcare Cancer Care
mi
from
Butte, MT
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
St. James Healthcare Cancer Care
mi
from
Butte, MT
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Great Falls Clinic - Main Facility
mi
from
Great Falls, MT
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Great Falls Clinic - Main Facility
mi
from
Great Falls, MT
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Clinical Research Facility
mi
from
Great Falls, MT
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Clinical Research Facility
mi
from
Great Falls, MT
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
St. Peter's Hospital
mi
from
Helena, MT
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
St. Peter's Hospital
mi
from
Helena, MT
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Glacier Oncology, PLLC
mi
from
Kalispell, MT
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Glacier Oncology, PLLC
mi
from
Kalispell, MT
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Kalispell Medical Oncology at KRMC
mi
from
Kalispell, MT
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Kalispell Medical Oncology at KRMC
mi
from
Kalispell, MT
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Kalispell Regional Medical Center
mi
from
Kalispell, MT
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Kalispell Regional Medical Center
mi
from
Kalispell, MT
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Community Medical Center
mi
from
Missoula, MT
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Community Medical Center
mi
from
Missoula, MT
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Guardian Oncology and Center for Wellness
mi
from
Missoula, MT
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Guardian Oncology and Center for Wellness
mi
from
Missoula, MT
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Montana Cancer Specialists at Montana Cancer Center
mi
from
Missoula, MT
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Montana Cancer Specialists at Montana Cancer Center
mi
from
Missoula, MT
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Montana Cancer Center
mi
from
Missoula, MT
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Montana Cancer Center
mi
from
Missoula, MT
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Rutherford Hospital
mi
from
Rutherfordton, NC
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Rutherford Hospital
mi
from
Rutherfordton, NC
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Bismarck Cancer Center
mi
from
Bismarck, ND
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Bismarck Cancer Center
mi
from
Bismarck, ND
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Medcenter One Hospital Cancer Care Center
mi
from
Bismarck, ND
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Medcenter One Hospital Cancer Care Center
mi
from
Bismarck, ND
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Mid Dakota Clinic, PC
mi
from
Bismarck, ND
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Mid Dakota Clinic, PC
mi
from
Bismarck, ND
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
St. Alexius Medical Center Cancer Center
mi
from
Bismarck, ND
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
St. Alexius Medical Center Cancer Center
mi
from
Bismarck, ND
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
CCOP - MeritCare Hospital
mi
from
Fargo, ND
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
CCOP - MeritCare Hospital
mi
from
Fargo, ND
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Sanford Broadway Clinic
mi
from
Fargo, ND
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Sanford Broadway Clinic
mi
from
Fargo, ND
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Mary Rutan Hospital
mi
from
Bellefontaine, OH
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Mary Rutan Hospital
mi
from
Bellefontaine, OH
Click here to add this to my saved trials